• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Annual Research Report

多発性骨髄腫におけるIG転座,PVT1,DCCの分子遺伝学的解析と臨床応用

Research Project

Project/Area Number 22591045
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

谷脇 雅史  京都府立医科大学, 医学研究科, 教授 (80163640)

Keywords多発性骨髄腫 / SKY / FISH / ゲノムアレイ / 遺伝子再構成
Research Abstract

多発性骨髄腫細胞株で見出されたt(8;13)(q24;q13)を多色蛍光染色体解析(SKY)法とアレイで解析した.8q24の切断点は,ゲノムの増減を認めるPVT1内の第1エキソン近傍にあることが推定された.同領域を中心にcDNA bubble PCRで解析し,得られた遺伝子産物をサブクローニング,塩基配列を検討,キメラを形成する相手遺伝子としてNeurobeachin(NBEA)を同定した.NBEAは13q13に存在し多発性骨髄腫で高頻度に欠失することが報告されている,PVT1-NBEAキメラ遺伝子は,PVT1のエキソン1とNBEAのエキソン3で融合しており,NBEAのエキソン2のスタートコドンが欠失しエキソン3のATGがスタートコドンとなることが予想される.RT-PCRの結果,N末端を欠くと考えられる異常なNBEAの高発現を認めた.骨髄腫細胞株はさらに,10株を解析,4株でPVT1再構成を検出し,相手遺伝子を検索中である.一方,54例の多発性骨髄腫を対象にFISH法を用いてPVT1再構成検索した,PVT1をはさむ2種類のBACクローンと,PVT1をカバーする2種類のBACクローンをプローブとして2色でFISH法を行い,7例に異常を認め臨床像との関連性を検討中である.さらに,治療抵抗性骨髄腫の症例で見出されたt(4;8)(q13;q24)についても8q24の切断点をPVT1内に同定し,同様にcDNA bubble PCRで解析中である.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

PVT1再構成の転座相手としてNBEAを同定することができた.そのような報告は海外でもなされていない.現在,英文誌に投稿中である.

Strategy for Future Research Activity

PVT1再構成の相手遺伝子としてNBEAに加えて候補をいくつか見出しており,今後は新たなキメラ遺伝子の同定を継続する.また,キメラ遺伝子の機能解析を実施する.

  • Research Products

    (56 results)

All 2012 2011

All Journal Article (19 results) (of which Peer Reviewed: 18 results) Presentation (29 results) Book (8 results)

  • [Journal Article] Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation2012

    • Author(s)
      Kondo Y
    • Journal Title

      Cancer Sci

      Volume: 103 Pages: 782-790

    • DOI

      doi: 10.1111/j.1349-7006.2012.02211.x

    • Peer Reviewed
  • [Journal Article] Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.2012

    • Author(s)
      Gotou M
    • Journal Title

      Genes Chromosomes Cancer

      Volume: 51 Pages: 42-53

    • DOI

      doi: 10.1002/gcc.20929

    • Peer Reviewed
  • [Journal Article] ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.2012

    • Author(s)
      Ohshiro M
    • Journal Title

      Am J Hematol

      Volume: 87 Pages: 116-119

    • DOI

      doi: 10.1002/ajh.22185

    • Peer Reviewed
  • [Journal Article] Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma2012

    • Author(s)
      Kiyota M
    • Journal Title

      Int J Hematol

      Volume: Mar 17(Epub ahead of print)

    • Peer Reviewed
  • [Journal Article] Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma : a multicenter cooperative study in Japan2012

    • Author(s)
      Tokunaga T
    • Journal Title

      Blood

      Volume: 119 Pages: 2837-2843

    • Peer Reviewed
  • [Journal Article] Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study2012

    • Author(s)
      Matsuda A
    • Journal Title

      Leuk Res

      Volume: 36 Pages: 575-80

    • Peer Reviewed
  • [Journal Article] Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A2012

    • Author(s)
      Kobayashi T
    • Journal Title

      Acta Haematol

      Volume: 127 Pages: 10-15

    • Peer Reviewed
  • [Journal Article] Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma2011

    • Author(s)
      Kaneko H
    • Journal Title

      Asia Pac J Clin Oncol

      Volume: 7 Pages: 346-50

    • DOI

      doi:10.1111/j.1743-7563.2011.01432

    • Peer Reviewed
  • [Journal Article] Intravascular B-cell lymphoma with hypercalcemia as the initial presentation2011

    • Author(s)
      Chinen Y
    • Journal Title

      Int J Hematol

      Volume: 94 Pages: 567-570

    • Peer Reviewed
  • [Journal Article] Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma : JCOG 0203 trial2011

    • Author(s)
      Watanabe T
    • Journal Title

      J Clin Oncol

      Volume: 29 Pages: 3990-3998

    • Peer Reviewed
  • [Journal Article] Cytogenetic and molecular abnormalities in myelodysplastic syndrome2011

    • Author(s)
      Nagoshi H
    • Journal Title

      Curr Mol Med

      Volume: 11 Pages: 678-685

  • [Journal Article] Cytotoxic molecule-positive classical Hodgkin's lymphoma : a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type2011

    • Author(s)
      Asano N
    • Journal Title

      Haematologica

      Volume: 96 Pages: 1636-1643

    • Peer Reviewed
  • [Journal Article] Eμ/miR-125b transgenic mice develop lethal B-cell malignancies2011

    • Author(s)
      Enomoto Y
    • Journal Title

      Leukemia

      Volume: 25 Pages: 1849-1856

    • DOI

      doi:10.1038/leu.2011.166

    • Peer Reviewed
  • [Journal Article] Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bc1-2 and c-Myc overexpression2011

    • Author(s)
      Sasaki N
    • Journal Title

      Exp Hematol

      Volume: 39(8) Pages: 817-828

    • Peer Reviewed
  • [Journal Article] Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma2011

    • Author(s)
      Ogura M
    • Journal Title

      Cancer Sci

      Volume: 102 Pages: 1687-1692

    • DOI

      doi:10.1111/j.1349-7006.2011.01994.x

    • Peer Reviewed
  • [Journal Article] Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes2011

    • Author(s)
      Uchida T
    • Journal Title

      Cancer Sci

      Volume: 102 Pages: 1680-1686

    • DOI

      doi:10.1111/j.1349-7006.2011.01993.x

    • Peer Reviewed
  • [Journal Article] Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome2011

    • Author(s)
      Mizutani S
    • Journal Title

      Acta Haematol

      Volume: 126 Pages: 8-12

    • Peer Reviewed
  • [Journal Article] Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronicmyeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis2011

    • Author(s)
      Kobayashi Y
    • Journal Title

      Int J Hematol

      Volume: 93 Pages: 745-749

    • Peer Reviewed
  • [Journal Article] Galectin-3 (Ga1-3)induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia2011

    • Author(s)
      Yamamoto-Sugitani M
    • Journal Title

      Proc Natl Acad Sci USA

      Volume: 108 Pages: 17468-17473

    • Peer Reviewed
  • [Presentation] 高齢者高リスク骨髄性造血器腫瘍に対するFlu/Bu16を前処置とした同種造血幹細胞移植療法2012

    • Author(s)
      古林勉
    • Organizer
      第34回日本造血細胞移植学会総会
    • Place of Presentation
      大坂
    • Year and Date
      2012-02-24
  • [Presentation] Low-dose cyclophosphamide (LD-CY)・G-CSF併用による末梢血幹細胞採取(PBSCC)の試み2012

    • Author(s)
      志村勇司
    • Organizer
      第34回日本造血細胞移植学会総会
    • Place of Presentation
      大坂
    • Year and Date
      2012-02-24
  • [Presentation] 8q24異常を伴う多発性骨髄腫におけるPVT1の関与および新規キメラ遺伝子PVT1-NBEAの同定2011

    • Author(s)
      名越久朗
    • Organizer
      第36回日本骨髄腫研究会総会
    • Place of Presentation
      東京
    • Year and Date
      20111100
  • [Presentation] 予後不良染色体異常を有する再発・難治性骨髄腫に対するボルテゾミブの効果2011

    • Author(s)
      黒田純也
    • Organizer
      第36回日本骨髄腫研究会総会
    • Place of Presentation
      東京
    • Year and Date
      20111100
  • [Presentation] Frequent rearrangements of PVT1 and a novel PVT1-NBEA chimeric gene in multiple myeloma2011

    • Author(s)
      Nagoshi H, Taki T, Hanamura I, Nishida K, Kuroda J, Okuda K, Kobayashi S, Yamamoto M, Tsutsumi Y, Kobayashi T, Matsumoto Y, Horiike S, Ootsuki T, Nitta M, Taniwaki M
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      20110000
  • [Presentation] Galectin-3 Is the Molecular Target for Overcoming Multidrug Resistance Due to the Cell Protection by Bone Marrow Leukemia Microenvironment in Chronic Myeloid Leukemia2011

    • Author(s)
      Shinsuke Mizutani
    • Organizer
      53th ASH Annual Meeting
    • Place of Presentation
      San Diego, USA
    • Year and Date
      2011-12-12
  • [Presentation] Frequent Involvement of PVT1 in Multiple Myeloma Carrying 8q24 Rearrangement and Identification of Novel PVT1-NBEA Chimeric Gene2011

    • Author(s)
      Hisao Nagoshi
    • Organizer
      53th ASH Annual Meeting
    • Place of Presentation
      San Diego, USA
    • Year and Date
      2011-12-12
  • [Presentation] Leukemia Microenvironment-Specific Galectin-3 Expression of Leukemic Cells Promotes Malignant Niche Formation and Bone Marrow Lodgment of leukemic Cells in Chronic Myelogenous Leukemia2011

    • Author(s)
      Junya Kuroda
    • Organizer
      53th ASH Annual Meeting
    • Place of Presentation
      San Diego, USA
    • Year and Date
      2011-12-10
  • [Presentation] Bc1-2 is a better target compared to c-Myc in novel DLBCL cell lines with Bc1-2/c-Myc overexpression2011

    • Author(s)
      Nana Sasaki
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-16
  • [Presentation] Biological analysis of AML1 arginine-mutant by means of in vitro differentiation of mouse ES cells2011

    • Author(s)
      Shinsuke Mizutani
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-16
  • [Presentation] Third line TKI therapy for two CML patients showing KD mutation and resistance to prior 2 TKIs2011

    • Author(s)
      Yuji Shimura
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-16
  • [Presentation] Rapid cytogenetic and molecular responses in newly diagnosed CML-CP patients treated with dasatinib2011

    • Author(s)
      Shigeo Horiike
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-16
  • [Presentation] Genome array and spectral karyotyping analysis of highly aggressive B-cell leukemia/lymphomas2011

    • Author(s)
      Yasuhiko Tsutsumi
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] Analysis of B-cell clonality and chromosomal abnormalities in IgG4-related disease2011

    • Author(s)
      Ryuko Nakayama
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] Analysis of BACH2-Telated genes in B-cell malignancies2011

    • Author(s)
      Satoru Kobayashi
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] Galectin-3 induced by leukemia microenvironment promotes drug resistance and BM lodgement in CML2011

    • Author(s)
      Mio Yamamoto
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] Clinical significance of cytogenetic abnormalities in acute myeloid leukemia : the JALSG AML201 study2011

    • Author(s)
      Tomohiko Taki
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] Rasburicase for the management of hyperuricemia in patients with hematological malignancies2011

    • Author(s)
      Hitoji Uchiyama
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
  • [Presentation] PhaseIII study of Lenalidomide plus Dexamethasone in Japanese Patients with R/R Myeloma2011

    • Author(s)
      Takaaki Chou
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-14
  • [Presentation] Roles of bortezomib as the induction for high dose therapy with autologous PBSCT in multiple myeloma2011

    • Author(s)
      Tsutomu Kobayashi
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-14
  • [Presentation] Bortezomib overcomes high risk cytogenetic abnormalities in relapsed/refractory multiple myeloma2011

    • Author(s)
      Miki Kiyota
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-14
  • [Presentation] Clinical outcomes of gastrointestinal tract B-cell lymphoma2011

    • Author(s)
      Hiroto Kaneko
    • Organizer
      第73回日本血液学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-14
  • [Presentation] マウスES細胞in vitro血球分化実験システムを用いたRUNX1/AML1のアルギニンメチル化の生物学的意義の検討2011

    • Author(s)
      水谷信介
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-03
  • [Presentation] B細胞腫瘍におけるBACH2関連遺伝子の発現解析2011

    • Author(s)
      小林覚
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-03
  • [Presentation] 多発性骨髄腫の8q24異常におけるPVT1遺伝子再構成2011

    • Author(s)
      名越久朗
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-03
  • [Presentation] 血液腫瘍におけるFISHの応用:間期核診断と転座関連遺伝子の単離2011

    • Author(s)
      谷脇雅史
    • Organizer
      第52回日本組織細胞化学会総会・学術集会
    • Place of Presentation
      石川(招待講演)
    • Year and Date
      2011-09-25
  • [Presentation] 再発、難知性、二次性中枢神経悪性リンパ腫に対する自家末梢血幹細胞移植併用大量化学療法2011

    • Author(s)
      志村勇司
    • Organizer
      第9回日本臨床腫瘍学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2011-07-23
  • [Presentation] Analysis of B-cell clonality and chromosomal abnormality characteristic of MALT lymphoma in IgG4-related disease2011

    • Author(s)
      中山理祐子
    • Organizer
      第51回日本リンパ網内系学会総会
    • Place of Presentation
      福岡
    • Year and Date
      2011-07-02
  • [Presentation] シクロスポリンが著効した化学療法抵抗性血管免疫芽球性T細胞リンパ腫2011

    • Author(s)
      古林勉
    • Organizer
      第95回近畿血液学地方会
    • Place of Presentation
      兵庫
    • Year and Date
      2011-06-18
  • [Book] Annual Review 2012(分担執筆)2012

    • Author(s)
      松本洋典、谷脇雅史
    • Total Pages
      140-150
    • Publisher
      中外医学者
  • [Book] メディカルサイエンス遺伝子検査学(分担執筆)2012

    • Author(s)
      谷脇雅史、滝智彦、坂元奈津美
    • Total Pages
      73-76
    • Publisher
      近代出版
  • [Book] 新薬展望2012(分担執筆)2012

    • Author(s)
      谷脇雅史
    • Total Pages
      180-184
    • Publisher
      医薬ジャーナル社
  • [Book] 私のこの一枚標本に学ぶ血液疾患症例(分担執筆)2012

    • Author(s)
      谷脇雅史
    • Total Pages
      401-406、407-413
    • Publisher
      医薬ジャーナル社
  • [Book] 血液専門医テキスト(分担執筆)2011

    • Author(s)
      谷脇雅史
    • Total Pages
      60-62
    • Publisher
      南江堂
  • [Book] 白血病診療ポケットブック(分担執筆)2011

    • Author(s)
      知念良顕、谷脇雅史
    • Total Pages
      67-78
    • Publisher
      中外医学社
  • [Book] 白血病・リンパ腫・骨髄腫-今日の診断と治療(分担執筆)2011

    • Author(s)
      谷脇雅史、松本洋典、黒田純也
    • Total Pages
      456-465
    • Publisher
      中外医学社
  • [Book] 造血器腫瘍取扱い規約(分担執筆)2011

    • Author(s)
      谷脇雅史
    • Total Pages
      128-133
    • Publisher
      金原出版株式会社

URL: 

Published: 2013-06-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi